DE69816367D1 - Benzolsulfonamidderivate - Google Patents

Benzolsulfonamidderivate

Info

Publication number
DE69816367D1
DE69816367D1 DE69816367T DE69816367T DE69816367D1 DE 69816367 D1 DE69816367 D1 DE 69816367D1 DE 69816367 T DE69816367 T DE 69816367T DE 69816367 T DE69816367 T DE 69816367T DE 69816367 D1 DE69816367 D1 DE 69816367D1
Authority
DE
Germany
Prior art keywords
alkyl
receptor
vinylene
trifluoromethyl
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69816367T
Other languages
English (en)
Other versions
DE69816367T2 (de
Inventor
Shuichi Ohuchida
Yuuki Nagao
Takayuki Maruyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69816367D1 publication Critical patent/DE69816367D1/de
Publication of DE69816367T2 publication Critical patent/DE69816367T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69816367T 1997-05-15 1998-05-14 Benzolsulfonamidderivate Expired - Fee Related DE69816367T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14095997 1997-05-15
JP14095997 1997-05-15

Publications (2)

Publication Number Publication Date
DE69816367D1 true DE69816367D1 (de) 2003-08-21
DE69816367T2 DE69816367T2 (de) 2004-04-15

Family

ID=15280803

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816367T Expired - Fee Related DE69816367T2 (de) 1997-05-15 1998-05-14 Benzolsulfonamidderivate

Country Status (14)

Country Link
US (1) US6235777B1 (de)
EP (1) EP0878465B1 (de)
KR (1) KR19980087031A (de)
CN (1) CN1201786A (de)
AT (1) ATE245141T1 (de)
AU (1) AU6600898A (de)
CA (1) CA2237709A1 (de)
DE (1) DE69816367T2 (de)
DK (1) DK0878465T3 (de)
ES (1) ES2203892T3 (de)
HU (1) HUP9801089A3 (de)
NO (1) NO982205L (de)
PT (1) PT878465E (de)
ZA (1) ZA984040B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6180600A (en) * 1999-07-29 2001-02-19 Ono Pharmaceutical Co. Ltd. Sulfonamide derivatives and remedies for allodynia
GB9930082D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
SE0100873D0 (sv) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
WO2002072145A1 (fr) * 2001-03-14 2002-09-19 Ono Pharmaceutical Co., Ltd. Remedes antidepresseurs contenant un antagoniste ep1 en tant que principe actif
US20060100195A1 (en) * 2001-11-19 2006-05-11 Takayuki Maruyama Remedies for urinary frequency
GB0317500D0 (en) * 2003-07-25 2003-08-27 Pfizer Ltd Treatment of bph
AU2005295821A1 (en) * 2004-10-12 2006-04-27 Decode Genetics Ehf Carboxylic acid peri - substituted bicyclics for occlusive artery disease
AU2005295902A1 (en) * 2004-10-12 2006-04-27 Decode Genetics Ehf Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease
MX2007004525A (es) * 2004-10-12 2007-09-19 Decode Genetics Inc Sulfonamidas biciclicas peri-sustituidas para enfermedad de arteria oclusiva.
US7579483B2 (en) * 2006-05-16 2009-08-25 Decode Genetics, Ehf. Process for preparing 7-(acryloyl)indoles
TW200817319A (en) * 2006-08-10 2008-04-16 Astellas Pharma Inc Sulfonamide compound or salt thereof
KR101492552B1 (ko) 2007-02-16 2015-02-12 오노 야꾸힝 고교 가부시키가이샤 요 배출 장애 치료제
CN106748951B (zh) 2012-07-19 2020-07-24 开曼化学股份有限公司 作为在治疗ep4介导的疾病和病状中使用的ep4受体选择性激动剂的二氟内酰胺化合物
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
AU2014290512A1 (en) 2013-07-19 2015-11-12 Cayman Chemical Company, Inc. Methods, systems, and compositions for promoting bone growth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1278577C (en) 1985-11-18 1991-01-02 Tatsuo Tsuri Bicyclic sulfonamide derivatives
JP2565746B2 (ja) * 1987-10-23 1996-12-18 小野薬品工業株式会社 新規な炭素環系スルホンアミド誘導体
EP0312906A3 (de) * 1987-10-23 1990-09-05 Ono Pharmaceutical Co., Ltd. Sulfonamidderivate
CA2113787A1 (en) 1993-01-29 1994-07-30 Nobuyuki Hamanaka Carbocyclic sulfonamides

Also Published As

Publication number Publication date
ATE245141T1 (de) 2003-08-15
ES2203892T3 (es) 2004-04-16
HU9801089D0 (en) 1998-07-28
NO982205L (no) 1998-11-16
EP0878465B1 (de) 2003-07-16
DE69816367T2 (de) 2004-04-15
HUP9801089A3 (en) 2001-08-28
US6235777B1 (en) 2001-05-22
EP0878465A2 (de) 1998-11-18
PT878465E (pt) 2003-12-31
CN1201786A (zh) 1998-12-16
ZA984040B (en) 1998-11-20
EP0878465A3 (de) 2001-03-14
AU6600898A (en) 1998-11-19
DK0878465T3 (da) 2003-11-03
CA2237709A1 (en) 1998-11-15
HUP9801089A2 (hu) 1999-11-29
NO982205D0 (no) 1998-05-14
KR19980087031A (ko) 1998-12-05

Similar Documents

Publication Publication Date Title
DE69816367D1 (de) Benzolsulfonamidderivate
ZA986801B (en) Chemical compound.
ATE210650T1 (de) Sulfonamid substituierte benzopyrane als kaliumkanalaktivatoren
NO20003111L (no) Orto-antranilamidderivater som antikoagulanter
DE60018225D1 (de) Oxamsäuren mit einer Cyanogruppe als Liganden für den Thyroidrezeptor
IT1256259B (it) Composti mettallocenici aventi leganti di tipo fluorenilico
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
KR970704864A (ko) 세정제 조성물
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DE69808619D1 (de) Prostaglandin-pharmazeutische-zusammensetzungen
CA2221110A1 (en) Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
DE60228990D1 (de) Bicyclische verbindung
UY24010A1 (es) Nuevos pirrolocarbazoles
HU9904634D0 (en) New thiaazolidine-derivatives
IS5497A (is) Bífenýlamidínafleiður
DK0984980T3 (da) 20-aralkyl-5alfa-pregnan-derivater
FI870090A (fi) Laongkedjade alkylresorcinolfosfiter.
ATE59372T1 (de) Fluessigkristallverbindung vom tolan-typ.
NO20022611L (no) Brodannede metallocenforbindelser som olefin- polymerisasjonskatalysatorer
NO983133L (no) Flytforbedrende middel for mineraloljer
BR0002516A (pt) Compostos úteis em terapia
DK1347960T3 (da) Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
BR0007897A (pt) Uso de derivados anticonvulsivantes para otratamento de bulimia nervosa
BR0205164A (pt) Processo para purificar azeotropicamente material orgânico polimerizável aquoso

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee